You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Correction: Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

Article metrics

Article menu

Download PDFPDF

Correction
Correction: Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2025

AbstractFullPdf
Nov 2021013634
Dec 202107014
Jan 20220277
Feb 202201610
Mar 20220154
Apr 20220168
May 20220427
Jun 202208517
Jul 20220152
Aug 20220291
Sep 20220166
Oct 202202610
Nov 2022095
Dec 2022040
Jan 20230610
Feb 20230212
Mar 2023032
Apr 2023061
May 2023072
Jun 2023041
Jul 202301010
Aug 2023033
Sep 2023052
Oct 2023033
Nov 2023091
Dec 20230176
Jan 20240154
Feb 20240159
Mar 20240127
Apr 2024048
May 20240120
Jun 20240142
Jul 20240206
Aug 2024095
Sep 2024066
Oct 2024065
Nov 20240137
Dec 2024071
Jan 2025095
Feb 2025061
Mar 2025041
Apr 202503617
May 202501110
Jun 20250125
Jul 2025010
Sep 2025010
Total0813267